Echosens shares a mission with the Fatty Liver Foundation to reach into every community in America to ensure asymptomatic individuals receive the screening and care they need.
edApril 7, 2020
Media center
Welcome to the Echosens North America media center. Here you will find articles, blogs & events regarding the latest trends in non-invasive liver diagnostics
Non-alcoholic fatty liver disease (NAFLD), affects approximately 100 million individuals in the United States. Its more serious form is called non-alcoholic steatohepatitis (NASH). NAFLD affects approximately 25% of the worldwide…
edMarch 30, 2020
Echosens shares a mission with the Fatty Liver Foundation to reach into every community in America to ensure asymptomatic individuals receive the screening and care they need.
Robert CipollettiFebruary 10, 2020
Echosens proudly announces the publication of the "FibroScan-AST (FAST) Score in The Lancet Gastroenterology & Hepatology.
Robert CipollettiFebruary 4, 2020
Echosens aligns with the Fatty Liver Foundation to accelerate screening for undiagnosed NAFLD-NASH patients.
Robert CipollettiJanuary 22, 2020
Contact a representative
In North America there are over 1200+ FibroScan systems in operation & we’re growing!
Speak to a Representative